A homogeneous high-throughput screening method based on time-resolved fluorescence resonance energy transfer (TR-FRET) for the measurement of calcium-dependent multimerization of an EF-hand protein, sorcin, is described. The assay is based on a specific sorcin binding peptide conjugated either with an intrinsically highly fluorescent europium chelate (donor) or an Alexa Fluor 700 fluorophore (acceptor). Addition of calcium results in multimerization of sorcin, allowing several peptides to bind simultaneously to the epitopes of the multimeric protein complex, and the proximity of peptides labeled either with donor or acceptor label results in fluorescence resonance energy transfer between the 2 labels. When no calcium is present, the protein remains in a monomer form, and thus no FRET can take place. In the optimized assay construct, the assay was performed in 45 min, and a more than 20-fold signal-to-background ratio was achieved. The reversibility of sorcin multimerization was shown by chelating free calcium with ethylenediamine tetraacetic acid (EDTA). The developed homogeneous assay can be used in screening molecules that either inhibit or enhance multimerization of sorcin, and the assay format is applicable to various noncompetitive high-throughput screening assays detecting protein multimerization reactions. (Journal of Biomolecular Screening 2007:842-848) 
INTRODUCTION
S UCCESSFUL MAPPING OF THE HUMAN GENOME and the obtained information has expanded our knowledge of molecules that contribute to different diseases. Candidate drug targets are discovered by means of genomics and proteomics, which reveal abnormal gene transcription or protein translation. Highthroughput screening (HTS) methods are essential for testing a large number of diverse potential drug candidates against disease targets. In HTS, possible drug molecules are usually screened with homogeneous assay systems, which are most often based on fluorescence technologies, where change in signal is a consequence of specific binding. Detection methods are based on, for example, fluorescence polarization, fluorescence correlation spectroscopy, and fluorescence resonance energy transfer (FRET). 1, 2 Fluorescence-based techniques possess high sensitivity and amenability to automation, offering the opportunity to simplify, miniaturize, and speed up assays.
FRET is one of the most used fluorescence-based technologies. 3 Upon specific binding, a donor and an acceptor molecule are brought into close proximity, and the energy is transferred from the donor to the acceptor if the acceptor is within 1-to 10nm distance from the donor. To be excited, the excitation spectrum of the acceptor should overlap with the emission spectrum of the donor. A long-lifetime fluorescent donor prolongs the lifetime of sensitized acceptor emission and enables timeresolved measurement of energy transfer from the donor to a conventional acceptor with short fluorescent lifetime. When the sensitized acceptor emission is measured with time-resolved mode, the background fluorescence is minimized, and sensitive assay methods can be developed. Currently, there are several commercial time-resolved FRET (TR-FRET)-based detection technologies available-for example, HTRF (Cisbio International/ Packard Biosciences, Bedford, MA), LANCE and TruPoint (PerkinElmer Life and Analytical Sciences, Turku, Finland), and LanthaScreen (Invitrogen, Carlsbad, CA), which all use lanthanide chelates as donor labels.
Sorcin (soluble resistance-related calcium binding protein), which belongs to a penta-EF-hand (PEF) family, was selected as the target for the development of a novel screening assay. Sorcin is expressed in a number of normal tissues, such as skeletal muscle, kidney, and brain, but most abundantly in the cardiac muscle. 4, 5 Like all proteins of the PEF family, sorcin undergoes a rapid conformational change when binding to calcium with EF-hand motifs consisting of 2 alpha-helix loops (E and F). After calcium binding, the overall hydrophobicity of the protein increases, and this leads to translocation from the cytoplasm to cell membranes, resulting in calcium-dependent interaction with other proteins (e.g., the ryanodine receptor). In the absence of calcium, sorcin exists as monomers or homodimers. At sorcin concentrations up to 10 µmol/L, sorcin is found as a monomer form. 6 After interaction with calcium, sorcin forms homotetramers or larger complexes. 7, 8 Development of a screening assay to find compounds that bind to sorcin could be used to enlighten sorcin's role and function in the cardiac tissue. Sorcin-binding molecules that either enhance or inhibit its capability to multimerize upon interaction with calcium might be used to examine sorcin as a potential drug target.
The aim was to develop a homogeneous assay detecting sorcin multimerization based on TR-FRET technology. We used specific sorcin-binding peptides that were labeled with suitable donor and acceptor labels. Upon sorcin multimerization and specific binding of the conjugated peptides, the donor and acceptor labels are brought into close proximity, and the energy is transferred from the excited donor to the acceptor, leading to sensitized acceptor emission. Because the acceptor emission is measured at near-infrared wavelengths with time-resolved mode, the background signal is minimal, which increases the sensitivity of the assay. A specific antibody against sorcin was also tested, and its performance was compared to the peptidebased assay. The kinetics and overall performance of the assay was optimized and evaluated.
MATERIALS AND METHODS

Recombinant sorcin and antibody
Expression of recombinant sorcin in Escherichia coli and its purification were carried out as described in Meyers et al. 4, 5 Lyophilized sorcin was stored at -70 °C and reconstituted into an optimized assay buffer containing 50 mM 4-morpholinepropanesulfonic acid (MOPS; pH 7.2), 0.1 mM Bapta, 0.01% Tween-40, and 0.5% bovine serum albumin (BSA) prior to use. Bapta (tetrapotassium salt), a calcium-specific chelator, was purchased from Invitrogen (Leiden, The Netherlands), and BSA (Pentex) was purchased from Bioreba (Reinach, Switzerland).
Mouse antisorcin monoclonal antibody (clone 25B3, mouse IgG) was purchased from Zymed Laboratories (San Francisco, CA). The antibody was raised against a peptide from the N-terminus of sorcin.
Sorcin-binding peptides
The specific sorcin-binding peptide (NeoMPS, Strasbourg, France) consisted of 20 amino acids, and the sequence was part of the annexin VII (synexin) N-terminal domain (MSYP-GYPPTGYPPFPGYPPA). 9 To enable site-specific labeling of the peptide, 1 or 3 lysines were added to the N-terminus.
Labeling reactions
Peptide with 3 lysines was labeled with intrinsically fluorescent nonadentate europium chelate with 2 chromophores and hydrophilic α-galactose side groups {2,2,′2′,′2′′′-{[2-(4isothiocyanatophenyl)ethylimino]bis(methylene)bis{4-{[4-(αgalactopyranoxy)phenyl]ethynyl}pyridine-6,2-diyl}bis(methyle nenitrilo)}tetrakis(acetato)}europium(III). 10 A prompt fluorophore Alexa Fluor 700 succinimidyl ester (Invitrogen) was conjugated to the peptide with 1 lysine. Conjugation of labels was performed in 50 mmol/L carbonate buffer (pH 9.8 for europium chelate and pH 9.3 for Alexa Fluor 700) overnight at 4 °C, and a 5-fold molar excess of the label molecules was used. The concentration of the peptides in conjugation reactions was 2 mg/mL. Both labeled peptides were purified with reversephase high-performance liquid chromatography (HPLC) using a µRPC C2/C18-column (Amersham Biosciences, Uppsala, Sweden) and an increasing acetonitrile gradient (25%-45%). Matrixassisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (Voyager DE Pro, Perseptive Biosystems, Boston, MA) was used to identify the purified products. The concentrations of the labeled peptides were determined with absorbance measurements. For Alexa Fluor 700-labeled peptide, the absorbance was measured at wavelength 280 nm, and a correction factor of 0.07 was used, according to the manufacturer's instructions, to calculate the correct concentration. For europium-labeled peptide, the concentration of Eu 3+ was determined against 1 nmol/L Eu standard solution diluted to Delfia enhancement solution (Turku University, Department of Biotechnology, Turku, Finland), and peptide concentration was determined by measuring absorbance at 280 nm and by using a correction factor (0.29), which was experimentally determined at Turku University. Labeled peptides were stored at -20 °C in small aliquots.
The sorcin-binding peptide was biotinylated with EZ-Link sulfo-NHS-LC-LC-biotin (Pierce Biotechnology, Rockford, IL) in 50 mmol/L carbonate buffer (pH 9.8) with 50-fold molar excess of the biotin reagent. The reaction was incubated for 4 h at room temperature, after which free biotin was removed with NAP-5 and NAP-10 gel filtration columns (GE Healthcare Life Sciences, Uppsala, Sweden) following the manufacturer's instructions using 50 mmol/L Tris-HCl (pH 7.75) containing 0.9% (w/v) NaCl and 0.05% (w/v) NaN 3 .
The antisorcin monoclonal antibody was labeled with europium(III) chelate of N 1 -(4-isothiocyanatobenzyl) diethylenetriamine-N 1 , N 2 ,N 3 ,N 4 -tetrakis (acetic acid) or biotinylated with biotin-isothiocyanate (University of Turku, Finland) in 50 mmol/L carbonate buffer (pH 9.8), and the reactions were purified using NAP-5 and NAP-10 gel filtration columns as described above.
Heterogeneous sandwich assay formats
Heterogeneous assays were performed by using biotinylated antibody or peptide as a capturing component and labeled antibody as a detection component. The principle in the antibodyantibody-based assay was to bind the capture and detection antibodies simultaneously to the sorcin oligomers, which contain at least 2 identical epitopes. The peptide was studied as an alternative binder and compared to the monoclonal antibody. All the assay components were diluted to the optimized assay buffer in the presence or absence of 1 mmol/L free calcium. The DELFIA wash buffer and the DELFIA enhancement solution were from Wallac, PerkinElmer Life and Analytical Sciences. The wash buffer was supplemented with 0.1 mmol/L Bapta and 1 mmol/L CaCl 2 in the reactions with calcium. Shortly, the assay was performed using streptavidin-coated plates (Innotrac Diagnostics, Turku, Finland), to which either 30 ng of biotinylated peptide or 100 ng of biotinylated antibody was attached to saturate the well surface. After a 30-min incubation at room temperature and wash step, dilutions of sorcin (0.2-100 µg/mL) with 4 replicates and 50 ng of europiumlabeled antibody were added in a 50-µL volume per well. Reactions were incubated for 45 min at 37 °C, after which the wells were washed twice, europium signal was developed with enhancement solution, and measurement was performed with a Victor 1420 Multilabel Reader (Wallac, PerkinElmer Life and Analytical Sciences), using the DUG11 excitation filter and 615-nm band-pass emission filter.
Signal-to-background ratios were calculated by dividing signal obtained in the presence of calcium with the signal obtained in the absence of calcium. The ratio of variation was determined from the mean of 4 replicates and shown with SD error bars.
Homogeneous screening assay for molecules affecting sorcin multimerization
Homogeneous assays were performed in Maxisorb microtitration wells (NUNC, Roskilde, Denmark) that were passively coated with BSA to prevent nonspecific binding. 11 All the assay components were diluted in the optimized assay buffer, and altogether, 3 replicates were used in every experiment. Briefly, sorcin 15 µg/mL (in 20 µL) and the donor 160-nmol/L and the acceptor 440-nmol/L peptides (in 30 µL) were added to the well. Reactions were incubated for 45 min at 37 °C with slow shaking. Different concentrations of the donor and acceptorlabeled peptides and sorcin were evaluated (data not shown).
Also, the effect of calcium was examined by altering the calcium concentration from 0 to 1000 µmol/L. To detect reversibility of the complex formation, 1.5 mmol/L ethylenediamine tetraacetic acid (EDTA) was added to the reaction to chelate calcium. Sensitized energy transfer emissions at 730 nm were measured using a 1234 Fluorometer (Wallac, PerkinElmer Life and Analytical Sciences) equipped with a red-sensitive R2949 photomultiplier tube (Hamamatsu Photonics, Shimokanzo, Japan) and a DUG11 excitation filter (Wallac, PerkinElmer Life and Analytical Sciences). The europium was excited at a 320-nm wavelength. Emission signals were measured with a 730-nm band pass with a 10-nm bandwidth and RG715 long-wave pass filters (Coherent, Inc., Santa Clara, CA). Signal-to-background ratios were calculated similarly as with heterogeneous assay.
Characterization of energy transfer
The assay format was evaluated according to the efficiency of energy transfer, which depends on, among other things, the distance and the spectral characteristics between donor and acceptor. 3, 12 Efficiency of the energy transfer (E D ) was determined experimentally by measuring the relative intensities (I) of the donor (160 nmol/L) in the absence (I D ) or presence (I DA ) of the acceptor (440 nmol/L) (equation (1)). The assay format was further characterized with respect to the overlap integral of absorption and emission spectra (equation (2)) and Förster distance R 0 (equation (3)). 13, 14 Quantum efficiency for donor emission in the absence of acceptor was 0.127 and was used in the calculations; 10 also, 2/3 and 1.33 were used as values for κ 2 and n, respectively.
The emission spectrum of europium-labeled peptide was measured with the time-resolved mode in the assay buffer containing 1 mmol/L calcium (Cary Eclipse Fluorescence Spectrophotometer, Varian, Inc., Palo Alto, CA) (325-nm excitation, 450-to 850-nm emission, and 100-µs delay). The absorption (765-nm emission and 550-to 745-nm excitation) and emission (615-nm excitation and 665-to 745-nm emission) spectra of Alexa Fluor 700-labeled peptides were measured with the fluorescence mode. The decay time of the sensitized acceptors was measured with a Cary Eclipse Fluorescence Spectrophotometer with 160 nmol/L donor, 440 nmol/L acceptor, and 15 µg/mL sorcin in an optimized assay buffer supplemented with 1 mmol/L calcium to demonstrate, respectively, the prolonged lifetime of acceptor due to energy transfer from the long-lifetime donor.
RESULTS
Detection of sorcin multimerization in the presence of calcium
To study the multimerization of sorcin after the addition of calcium, heterogeneous sandwich assay formats were set up using either biotinylated peptide or antibody as binder and europiumlabeled antibody as detection antibody. In both heterogeneous assay formats, the monomer form remained undetectable, and signal was obtained only from reactions after the addition of calcium, indicating the formation of larger sorcin complexes. When different concentrations of sorcin were tested in the presence of calcium compared to reactions to the absence of calcium, multimerization was detected at protein concentrations of less than 0.5 µg/mL in both assay formats (signal-to-background ratios of 2.3 and 2.4 using biotinylated antibody or peptide, respectively). With a 100-µg/mL sorcin concentration, signal-to-background ratios of 16 and 32 were obtained in the assay formats using biotinylated antibody or peptide, respectively (Fig. 1) .
Performance of the homogeneous assay format
After demonstrating in the heterogeneous assay formats that sorcin multimerization was induced with calcium and was detectable with both antibodies and peptides, homogeneous assay formats were set up. Assay format using monoclonal antibodies did not perform as efficiently as with peptides, and thus the further optimization and evaluation of assay performance was done only using sorcin-binding peptides (Fig. 2) .
The amount of peptides labeled either with europium chelate or Alexa Fluor 700 was optimized. The optimum amount of donor peptide at various concentrations of sorcin was 160 nmol/L, whereas the optimum amount of the acceptor peptide was 440 nmol/L. The approximately triple amount of the acceptor peptide reflects the labeling degrees of the donor-and acceptor-labeled peptides, which were 1 and 3, respectively. Multimerization of sorcin and FRET between labeled peptides were detected when protein concentration was over 5 µg/mL (Fig. 3A,B ). With the highest tested sorcin concentration, 100 µg/mL, a signal-to-background ratio of 25 was obtained, thus demonstrating excellent performance for a homogeneous assay.
The assay kinetics and effects of calcium were studied. The kinetics of the reaction was fast, and maximum signal level was reached within 30 min. Thus, the incubation time of the assay was set to 45 min. The effect of calcium on sorcin multimerization FIG. 1. Heterogeneous sandwich assay using either biotinylated peptide (gray columns) or antibody (white columns) as capture component, as well as europium-labeled antibody as tracer, to detect sorcin multimerization at different sorcin concentrations. Results are shown as the signal-to-background ratio of the reaction with calcium compared to the reaction without calcium. Ratio was calculated from the mean signal level of 4 replicates, and ratio variation is represented with SD error bars.
FIG. 2.
The principle of the homogeneous assay. In the absence of calcium, sorcin remains a monomer (I), but multimers form rapidly after calcium is added (II). Peptides labeled either with the intrinsically highly fluorescent europium chelate (Eu) or with the Alexa Fluor 700 dye (A) were added to the reaction at the same time. Upon specific binding, the donor and acceptor labels are brought into close proximity, which enables fluorescence resonance energy transfer (FRET) to occur. was tested with increasing calcium concentrations (0-1000 µmol/L) and depicted in Figure 4 , demonstrating an increase in the signal-to-background ratio with increasing calcium. The multimerization was shown to be reversible because the signal decreased to the background level after removing free calcium from the assay solution with EDTA.
The homogeneous assay format was further characterized with respect to the efficiency of energy transfer, overlap of absorption, and emission spectra and Förster distance. 13, 14 The emission spectrum of the donor and excitation and emission spectra of the acceptor are depicted in Figure 5 . Estimation of the Förster distance, 51 Å, was based on the spectra. The efficiency of the energy transfer between labels determined with relative donor intensity was approximately 80%. The decay time of conventional acceptor was increased from a few nanoseconds to 78 µs.
DISCUSSION
Homogeneous assay formats that do not require separation steps and are simple to perform can be readily automated, reduce costs, and are thus suitable for HTS in drug discovery. Sorcin, a protein involved in Ca 2+ -dependent signaling pathways and most abundantly expressed in the cardiac muscle, was selected as a target protein for development of a homogeneous assay for the detection of sorcin multimerization. Calcium binding induces drastic changes in sorcin conformation and causes multimerization, which is required for its consequent functions and activity. The role of sorcin in cardiac diseases is not yet solved. However, modulating the activity of sorcin, either by inhibiting or enhancing it, might have major effects in the cardiac tissue, and thus sorcin is studied as a possible drug target. It is not quite clear whether sorcin forms tetramers, oligomers, or larger aggregates after calcium addition in our assay conditions or in vivo, but the overall change from monomer or dimer to a larger protein complex is the crucial event for its function and reactions with target proteins. To our knowledge, there are no previous reports describing immunochemical assays detecting sorcin protein or its multimer forms.
Our assay mimics homogeneous noncompetitive assays that apply donor-and acceptor-labeled antibodies against different epitopes of a protein molecule. 15, 16 The presence of an analyte in a sample brings the 2 labeled antibodies into close proximity, which results in FRET. However, our assay differs from these previous reports because it uses only 1 binding component, which is a peptide against 1 epitope, and FRET occurs only upon protein multimerization. Most of the FRET-based detection methods for protein multimerization reported so far have been applied to receptor-ligand studies in cellular systems and use recombinant fluorescent proteins. 17 We are not aware of any other HTS assays that apply donor-acceptor-labeled protein binders to detect protein multimerization.
The specific sorcin-binding peptide sequence 18 is part of the N-terminal domain of the annexin VII (synexin) protein, which belongs to a family of homologous proteins that have an ability to bind phospholipid membranes. Use of a specific peptide instead of a monoclonal antibody in the assay setup turned out to be a good choice, not just in light of cost issues and availability but also with respect to the assay performance (Fig. 1) . The smaller size of the peptide allowed efficient FRET to take place due to the shorter distance between the donor-and acceptor-labeled molecules (Fig. 2) . It has previously been shown that the annexin VII-derived peptide binds sorcin in a 1:2 molar ratio, thus suggesting that the peptide binds only to sorcin dimers. 18 In principle, at least sorcin tetramers are needed for the 2 peptides to bind simultaneously, and this was indeed shown in our results (Fig. 3A,B) because sorcin was detected only in conditions when calcium was present and larger complexes were formed. At low concentrations, sorcin exists as a monomer form that the peptide is unable to recognize. 6 In the peptide-labeling reactions, europium label was conjugated to peptide containing 3 lysines, allowing 3 labeled molecules to be attached, and this enabled efficient donor emission. The Alexa Fluor 700 was conjugated to the peptide that contains only 1 lysine because Alexa dyes have a tendency to quench each other's emission when they are in close proximity. 19 We also detected this phenomenon, and thus the peptide with only 1 lysine was labeled with Alexa. Lanthanide-chelate labels are efficient donors, which enable long Förster distance and efficient energy transfer. Because the emission spectrum of the donor has multiple emission peaks, it is possible to use conventional fluorescent dyes, which have a short Stokes shift, and it is still possible to avoid background fluorescence from the donor when sensitized emission is measured at the local emission minimum.
The signal-to-background ratio of more than 20 in the optimized assay is more than adequate for an assay where only a positive or negative result is required (Fig. 3A,B) . The multimerization reaction was shown to be reversible because the signal was decreased to the background level after removing free calcium from the assay solution with EDTA ( Fig. 4) . This proved that the sorcin multimerization reaction and its detection with labeled peptides and FRET was a specific reaction resulting from the effects of calcium.
When the donor-acceptor pair was examined more closely, it proved to be very effective for time-resolved energy transfer. In addition, the extremely low long-lifetime background fluorescence at 730 nm ( Fig. 5 ) improves sensitivity and assay performance because measurement of prolonged acceptor emission at a near-infrared field decreases interfering auto-fluorescence. The determined transfer efficiency, based on donor fluorescence intensities, was approximately 80%, which shows that the relative distance between donor and acceptor is less than the calculated Förster distance (51 Å), where efficiency of the energy transfer equals 50%. 13 However, donors that do not participate in fluorescence energy transfer with acceptors may cause interfering emission, and therefore the transfer efficiency is probably more efficient in real terms. The decay times of sensitized acceptors were also increased from a conventional few nanoseconds to approximately 80 µs. Decreased donor fluorescence intensity in the presence of acceptor and prolonged lifetime of the sensitized acceptor during FRET indicate that the long-lifetime europium chelate was indeed transferring its energy to the shorter lifetime acceptor.
Previously, it has been suggested that a high concentration of sorcin is required for it to oligomerize in the presence of calcium. 7 We were able to detect the multimerization of sorcin both with heterogeneous and homogeneous assay formats ( Figs. 1, 3A,B) at moderately low concentrations, which were 10-to 100-fold lower than reported earlier. The previous studies detected quenching of intrinsic protein fluorescence to demonstrate sorcin oligomer formation. 4, 5, 7, 8 Because this is the first report describing the detection of sorcin multimerization with immunochemical methods, the detection of multimerization at lower protein concentrations is most likely explained by fundamental differences between our and previous measurement methods. The more sensitive detection of sorcin multimerization enables characterization of weak interactions that might otherwise remain undetectable.
In conclusion, we have developed a simple, homogeneous assay based on TR-FRET for screening possible candidate drug molecules affecting sorcin multimerization. The sensitive detection of multimerization at low protein concentrations is an advantage when studying molecules that only weakly affect sorcin multimerization. The rapid degradation of the protein complex after removal of calcium demonstrates the specificity of the reaction and its suitability for screening purposes. The high signal-to-background ratio and fast reaction kinetics fulfill the demands for an automated HTS assay format that can be adapted to detect various protein multimerization reactions.
